| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/07/2006 | EP1666600A1 Methods for enhancing the efficacy of cancer therapy |
| 06/07/2006 | EP1666594A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666498A2 Soluble CTLA4 molecules, compositions comprising said molecules and uses thereof |
| 06/07/2006 | EP1666497A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666493A1 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 06/07/2006 | EP1666492A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666491A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666472A1 Phenylacetic acid derivative, process for producing the same, and use |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1666465A1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor |
| 06/07/2006 | EP1666464A1 Piperidine derivative having nmda receptor antagonistic activity |
| 06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
| 06/07/2006 | EP1666455A1 Amide type carboxamide derivative |
| 06/07/2006 | EP1666071A1 Preparation for the prophylaxis of restenose |
| 06/07/2006 | EP1666070A1 Preparation for the prophylaxis of restenose |
| 06/07/2006 | EP1666068A1 Remedy for eye diseases accompanied by optic nerve injuries |
| 06/07/2006 | EP1666066A1 Remedy for down syndrome |
| 06/07/2006 | EP1666064A1 Remedy for diseases associated with immunoglobulin gene translocation |
| 06/07/2006 | EP1666062A2 Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5c8 |
| 06/07/2006 | EP1666052A1 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 06/07/2006 | EP1666051A2 Remedies |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1666044A1 Male contraceptive formulation comprising norethisterone |
| 06/07/2006 | EP1666042A2 Composition comprising cilobradine and a cardiostimulating agent, e.g. telmisartan |
| 06/07/2006 | EP1666039A1 Use of L-alpha-lysophosphatidylcholine inhibitors to prevent inflammation |
| 06/07/2006 | EP1666034A1 Pharmaceutical combination comprising a biguanide |
| 06/07/2006 | EP1666033A1 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 06/07/2006 | EP1664006A2 Modulators of atp-binding cassette transporters |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663290A2 Modulators of p-selectin glycoprotein ligand 1 |
| 06/07/2006 | EP1663251A1 Use of 2-methylene-19-nor-20(s)-1a,25-dihydroxyvitamin d3 to increase the life expectancy of human beings |
| 06/07/2006 | EP1663203A1 Pharmaceutical compositions for the treatment of organophosphate poisoning |
| 06/07/2006 | EP1663194A2 Method of treating cancer with hdac inhibitors |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1427723B1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1423145B1 Compositions for the treatment of parkinson's disease containing a cb1 receptor antagonist and a product that activates dopaminergic neurotransmission in the brain |
| 06/07/2006 | EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1320552B8 Method for producing human anti-thymocyte immunoglobulins |
| 06/07/2006 | EP1315732B1 Radicicol and monocillin and their analogues and uses thereof |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1265629B1 Use of growth hormone in low dose |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1171594B1 Vascular endothelial cell growth factor variants and uses thereof |
| 06/07/2006 | EP1165112B1 Modulators of polysaccharides and uses thereof |
| 06/07/2006 | EP1162969B1 use of dipeptidyl peptidase IV inhibitors fOR IMPROVING FERTILITY |
| 06/07/2006 | EP1148783B1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 06/07/2006 | EP1147113B1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 06/07/2006 | EP1124592B1 Textured and porous silicone rubber |
| 06/07/2006 | EP1107794B1 Therapeutic compositions for the treatment of mucus hypersecretion |
| 06/07/2006 | EP1104307B1 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0939767B1 Porcine factor viii and hybrids thereof |
| 06/07/2006 | EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents |
| 06/07/2006 | CN1784426A Antibody targeted at antigen specific to cancer |
| 06/07/2006 | CN1784415A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/07/2006 | CN1784410A Protein kinase inhibitors |
| 06/07/2006 | CN1784405A Microcrystal |
| 06/07/2006 | CN1784215A Melanogenesis promoter and melanogenesis promoter composition |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781918A Process for producing thioester compound |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1781549A Adeno-associated virus vector preparation and medicinal composition containing it and its use |
| 06/07/2006 | CN1781545A Method for extracting herbal medicine |
| 06/07/2006 | CN1781542A Medicine for human body to disperse fragrance and its preparing method |
| 06/07/2006 | CN1781533A Health restoring agastache dripping pill preparation and its preparing method |
| 06/07/2006 | CN1781529A Liuweidihuang multiple vatimines and its preparing method |
| 06/07/2006 | CN1781500A Use of red yeast in preparing anti-inflammatory medicine |
| 06/07/2006 | CN1781498A Chinese herbal medicine oral liquid for treating sub-health and its preparing method |
| 06/07/2006 | CN1781488A Polyene phosphatidyl choline infusion solution and its preparing method |
| 06/07/2006 | CN1258536C Pineapple acid glycoside compound and its use |
| 06/07/2006 | CN1258533C Antihistaminic spiro compounds |
| 06/07/2006 | CN1258380C Utilization of ADAMTS-1 protein and method of screening aggrecanase activity regulator |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7057047 reacting 2-diaminopyridine with malic/sulfuric acid to form 2-amino-7-hydroxy-1,8-naphthyridine sulfuric acid salt, reacting in solvent to form phthalimidyl naphthyridine, chlorinating, reducing to hydroxyindolinone, then reacting with 5-methyl-2-oxo-hexyltriphenylphosphonium halide to form racemate |
| 06/06/2006 | US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
| 06/06/2006 | US7057036 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 06/06/2006 | US7057013 TGFβ1 inhibitor peptides |
| 06/06/2006 | US7056950 Compositions of biochemical compounds involved in bioenergy metabolism of cells |
| 06/06/2006 | US7056949 Liver disorders, dietetics; weight ratio of glycerides to diglycerides |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056942 Carvedilol |
| 06/06/2006 | US7056939 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3) |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056936 Synergistic combination |
| 06/06/2006 | US7056931 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 06/06/2006 | US7056928 anti-inflammatory, anti-pyretic and analgesic properties, without the potential side effects associated with inhibition of COX-1 |